Name: XFOR Balance Sheet - X4 Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

XFOR - X4 Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

XFOR Balance Sheet - X4 Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015
Cash And Short Term Investments
Cash And Equivalents	217.0	55.7	99.2	121.7	81.8	78.7	126.2	8.1	26.7	15.2	-
Restricted Cash	0.8	0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.0	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	217.0	55.7	99.2	121.7	81.8	78.7	126.2	8.1	26.7	15.2	-
Receivables
Accounts Receivable	0.6	1.1	0.0	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	2.8	0.0	-	-	-	-	-	-	-	-
Prepaid Expenses	3.5	5.6	7.3
Non-Current Assets
Property, Plant & Equipment Gross	1.4	2.7	2.4	2.3	2.2	1.5	0.7	0.4	2.6	-	-
Accumulated Depreciation	1.2
Current Liabilities
Accounts Payable	5.7	8.6	8.9	7.8	4.3	3.1	2.1	3.0	1.9	-	-
Short Term Debt	-	-	0.0
Non-Current Liabilities
Long Term Debt	75.0	75.0	54.6	32.3	33.1	33.2	20.0	8.3	-	-	-
Operating Lease Liabilities Non-Current	0.0	1.4
Common Equity
Common Stock	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	-	-	-
Supplementary Data
Total Debt	75.0	75.0	54.6	33.6	33.9	33.2	20.0	10.0	-	-	-
Net debt	(142.0)	19.3	(44.6)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q4 FY 15
Cash And Short Term Investments
Cash And Equivalents	216.9	217.0	69.6	39.2	40.3	55.7	97.4	147.2	60.5	99.2	131.6	136.4	93.4	121.7	79.9

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	2.5	3.5	4.9	5.0	4.5	5.6	4.5	5.0	5.8	7.3	5.8	5.5	4.2	5.8	5.0	4.4	3.6	5.3
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	242.0	261.6	132.8	72.9	95.7	112.2	143.0	175.4	87.3	122.1	147.9	147.6	98.2	128.7	85.7	52.6

Current Liabilities
Accounts Payable	5.1	5.7	5.1	7.7	11.1	8.6	8.6	8.0	8.9	8.9	8.1	5.1	6.0	7.8	3.8	3.7	3.6	4.3	2.4	2.5	3.1	3.1	3.9	1.8	1.2	2.1	1.7	3.1	6.1	3.0	2.1	2.1	1.1	1.9	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	0.0	0.8	0.6	1.3	14.6	8.6	3.4	0.8
Deferred Revenue Current	0.9	0.5	0.6	0.8	0.9	0.0	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	0.7	1.0	1.2	1.4	1.3	1.3	1.2	1.2	1.1	1.1	1.1	1.1	1.2	1.2	1.2	1.1
Accrued Expenses	17.1	18.6	16.7	13.1	12.6	23.0	19.5	19.7	13.5	12.8	16.2	15.2	11.8	12.0	9.1	8.6	6.9	7.9
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	23.8	25.8	23.5	22.9	25.9	32.9	29.3	28.9	23.5	22.9	25.4	22.3	19.5	22.3	28.7

Common Equity
Common Stock	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(614.8)	(594.6)	(570.6)	(540.8)	(515.1)	(515.4)	(475.5)	(438.8)	(529.7)	(477.9)	(458.8)	(456.5)	(400.8)	(376.7)	(347.6)	(326.0)	(304.8)
Accumulated Other Comprehensive Income	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.2)	(0.2)	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)	(0.1)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	168.5	186.3	61.6	4.0	22.9	22.1	59.6	94.5	1.0	51.1	67.6	67.5	51.7	74.1	61.8	30.1	49.7
Total Equity	168.5	186.3	61.6	4.0	22.9	22.1	59.6	94.5	1.0	51.1	67.6	67.5	51.7	74.1	61.8	30.1	49.7	64.4

Supplementary Data
Total Debt	75.0	75.0	75.0	75.0	75.0	75.0	75.0	75.0	55.0	55.0	55.0	33.3	33.1	33.8	47.1	41.1	35.9	33.3	33.2	32.5	32.5	32.5	25.0	25.0	25.0	20.0	20.0	26.3	19.5	10.0	-	-	-	-	-	-	-	-	-
Net debt	(141.9)	(142.0)	5.4	35.8	34.7	19.3	(22.4)	(72.2)	(5.5)	(44.2)	(76.6)	(103.2)	(60.4)	(87.9)	(32.7)	(6.3)	(30.5)	(48.5)
Working Capital	218.2	235.8	109.3	50.0	69.8	79.3	113.7	146.5	63.8	99.2	122.4	125.4	78.7	106.4	57.0	30.6	55.9	73.9
Book Value	168.5	186.3	61.6	4.0	22.9	22.1	59.6	94.5	1.0	51.1	67.6	67.5	51.7	74.1	61.8	30.1	49.7	64.4
Tangible Book Value	142.0	159.7	34.8	(23.0)	(4.2)	(5.2)	32.1	66.7	(16.3)	33.7	50.2	50.2	34.3	56.7	44.5	12.7	32.4